Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01073176 · ClinicalTrials.gov registry record · Phase 1

Training Executive, Attention and Motor Skills (TEAMS): Preliminary Studies

A Phase 1 study, sponsored by Queens College, The City University of New York.

Completed
Registry status
Phase 1
Development phase
30
Enrollment target

NCT01073176: Completed Phase 1 study, sponsored by Queens College, The City University of New York.

NCT01073176 is a Phase 1 study that has completed, run by Queens College, The City University of New York. The registered enrollment target is 30 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (50% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01073176, a Phase 1 study, has completed, sponsored by Queens College, The City University of New York.

COMPLETED
Registry status
Phase 1
Development phase
30 participants
Enrollment target

Study Summary

Training Executive, Attention and Motor Skills (TEAMS) is a new research program for preschool children with Attention-Deficit/Hyperactivity Disorder (ADHD) that attempts to use game-like activities and physical exercise to promote the growth of neural processes that underlie the core features of the disorder (e.g., hyperactivity, impulsivity) as well as associated areas of difficulty (e.g., socialization, motor skills). These activities are implemented at home and in supervised playgroups at no cost to families and are coupled with extensive parental education about ADHD symptoms and associated impairments.

Primary Outcome

Parents complete diaries indicating the games/exercises that they engaged in with their children, as well as the amount of time per day and the degree to which the activities were enjoyable.

Interventions

  • OTHER TEAMS (Training Attention Executive and Motor Skills)

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2009-04
Est. Completion 2011-03
Phase Phase 1

What the finished NCT01073176 record still lists

NCT01073176 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (50% lower).

The record links to 0 conditions, and to 1 intervention - of which TEAMS (Training Attention Executive and Motor Skills) is the first listed.

NCT01073176 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01073176 about?

NCT01073176 is a clinical study titled "Training Executive, Attention and Motor Skills (TEAMS): Preliminary Studies". Training Executive, Attention and Motor Skills (TEAMS) is a new research program for preschool children with Attention-Deficit/Hyperactivity Disorder (ADHD) that attempts to use game-like activities and physical exercise to promote the growth of neural processes that underlie the core features of th...

What is the current status of trial NCT01073176?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2009-04. Estimated completion is 2011-03.

What interventions are being tested in trial NCT01073176?

The interventions under investigation include: TEAMS (Training Attention Executive and Motor Skills) (OTHER).

Who is sponsoring clinical trial NCT01073176?

This trial is sponsored by Queens College, The City University of New York, which has 8 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01073176's enrollment target sits among peer trials

30 1332nd of 2000 higher than 561 of 2,000 other Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01073176, the US trial registry maintained by the National Library of Medicine. NCT01073176 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.